Op2Lysis is excited to announce the receipt of public funding from the Normandy Region and the FEDER FSE+ FTJ Normandie program for its THROMBO-STROKE collaborative project. Running from October 2024 to September 2027, the project aims to develop innovative models for ischemic stroke by addressing the critical challenge of clot heterogeneity. In collaboration with Inserm U1237, led by Professor Denis Vivien, Op2Lysis will focus on improving the translational relevance of preclinical models, with the goal of advancing stroke research and stimulating industrial developments. This project builds on Op2Lysis’ expertise in translational models, which has already resulted in a 2023 Brain journal publication.